RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers.
Cancers (Basel). 2020 Mar 7;12(3):620. doi: 10.3390/cancers12030620.
Cancers (Basel). 2020.
PMID: 32156016
Free PMC article.